Ad
related to: low folate but no anaemia in women over 60 mean cancer prognosis death
Search results
Results From The WOW.Com Content Network
Folate deficiency, also known as vitamin B 9 deficiency, is a low level of folate and derivatives in the body. [1] This may result in megaloblastic anemia in which red blood cells become abnormally large, and folate deficiency anemia is the term given for this medical condition. [3] Signs of folate deficiency are often subtle. [4]
Among women, however, no difference in life expectancy was seen. [17] More recently, however, a meta-analysis has shown that overall cancer rates are barely increased with an odds ratio of 1.07, which suggests that an impact on mortality from cancer is small or zero.
Low risk MDS (which is associated with favorable genetic variants, decreased myeloblastic cells [less than 5% blasts], less severe anemia, thrombocytopenia, or neutropenia or lower International Prognostic Scoring System scores) is associated with a life expectancy of 3–10 years. Whereas high risk MDS is associated with a life expectancy of ...
Among those over the age of 60, about 2% have the condition. [8] It more commonly affects people of northern European descent. [2] Women are more commonly affected than men. [15] With proper treatment, most people live normal lives. [5] Due to a higher risk of stomach cancer, those with pernicious anemia should be checked regularly for this. [13]
In this study, children born to mothers with high folate concentrations and low vitamin B 12 concentrations were found to have higher adiposity and insulin resistance at age 6. In the same study, over 60% of pregnant women were deficient in vitamin B 12, which was considered to increase the risk of gestational and later diabetes in the mothers ...
Comparing low to high dietary folate showed a modest but statistically significant reduced risk of colon cancer. [49] For prostate cancer risk, comparing low to high dietary folate showed no effect. [50] [51] A review of trials that involved folic acid dietary supplements reported a statistically significant 24% increase in prostate cancer risk ...
Myelodysplastic syndrome (MDS) is a form of blood cancer in which the bone marrow no longer produces enough healthy, normal blood cells. [9] MDS are a frequently unrecognized and rare group of bone marrow failure disorders, yet the incidence rate has rose from 143 reported cases in 1973 to approximately 15,000 cases in the United States each year.
It most commonly affects individuals over the age of 65, due to the accumulation of genetic mutations that occur over time. [3] [18] CLL is rarely seen in individuals less than 40 years old. [19] Men are more commonly affected than women, although the average lifetime risk for both genders are similar (around 0.5-1%) .